{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:16:53Z","timestamp":1777972613868,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11604-025-01937-9","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:37:06Z","timestamp":1768365426000},"page":"926-948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative indices from post-PRRT SPECT\/CT: an exploratory approach to early imaging biomarkers in neuroendocrine tumors"],"prefix":"10.1007","volume":"44","author":[{"given":"Takanori","family":"Bando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7165-6099","authenticated-orcid":false,"given":"Hideki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Otomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Azane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Takashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamato","family":"Kunikane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kawanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ikushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"1937_CR1","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","volume":"56","author":"T Ito","year":"2021","unstructured":"Ito T, Masui T, Komoto I, Doi R, Osamu RY, Sakurai A, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021;56:1033\u201344. https:\/\/doi.org\/10.1007\/s00535-021-01827-7.","journal-title":"J Gastroenterol"},{"key":"1937_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol"},{"key":"1937_CR3","doi-asserted-by":"publisher","first-page":"117955141988405","DOI":"10.1177\/1179551419884058","volume":"12","author":"R Wang","year":"2019","unstructured":"Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB. Management of gastrointestinal neuroendocrine tumors. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419884058. https:\/\/doi.org\/10.1177\/1179551419884058.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"1937_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22038\/AOJNMB.2021.56254.1390","volume":"10","author":"Y Inaba","year":"2022","unstructured":"Inaba Y, Hijioka S, Iwama I, Asai T, Miyamura H, Chatani S, et al. Clinical usefulness of somatostatin receptor scintigraphy in the diagnosis of neuroendocrine neoplasms. Asia Ocean J Nucl Med Biol. 2022;10:1\u201313. https:\/\/doi.org\/10.22038\/AOJNMB.2021.56254.1390.","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"1937_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.beem.2016.01.003","volume":"30","author":"T Baumann","year":"2016","unstructured":"Baumann T, Rottenburger C, Nicolas G, Wild D. Gastroenteropancreatic neuroendocrine tumors (GEP-NET) - imaging and staging. Best Pract Res Clin Endocrinol Metab. 2016;30:45\u201357. https:\/\/doi.org\/10.1016\/j.beem.2016.01.003.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1937_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000475526","volume":"105","author":"RJ Hicks","year":"2017","unstructured":"Hicks RJ, Kwekkeboom DJ, Krenning E, Bodei L, Grozinsky-Glasberg S, Arnold R, et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues. Neuroendocrinology. 2017;105:295\u2013309. https:\/\/doi.org\/10.1159\/000475526.","journal-title":"Neuroendocrinology"},{"key":"1937_CR7","first-page":"219","volume":"31","author":"EP Krenning","year":"1999","unstructured":"Krenning EP, Valkema R, Kooij PP, Breeman WA, Bak ker WH, deHerder WW, et al. Scintigraphy and radionuclide therapy with [indium 111-labeled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. Ital J Gastroenterol Hepatol. 1999;31:219\u201323.","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"1937_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12149-021-01592-w","volume":"35","author":"R Bando","year":"2021","unstructured":"Bando R, Otsuka H, Otani T, Matsuda N, Azane S, Kunikane Y, et al. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography. Ann Nucl Med. 2021;35:504\u201313. https:\/\/doi.org\/10.1007\/s12149-021-01592-w.","journal-title":"Ann Nucl Med"},{"key":"1937_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11604-022-01364-0","volume":"41","author":"N Matsuda","year":"2023","unstructured":"Matsuda N, Otsuka H, Otani T, Azane S, Kunikane Y, Otomi Y, et al. New quantitative indices of cardiac amyloidosis with 99mTc-pyrophosphate scintigraphy. Jpn J Radiol. 2023;41:428\u201336. https:\/\/doi.org\/10.1007\/s11604-022-01364-0.","journal-title":"Jpn J Radiol"},{"key":"1937_CR10","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.2967\/jnumed.124.267964","volume":"65","author":"O Tuncer","year":"2024","unstructured":"Tuncer O, Steinberger D, Steiner J, Hinojos M, Y. Rhee S, Humphrey B, et al. Quantitative SPECT\/CT metrics in early prediction of [177Lu]Lu-DOTATATE treatment response in gastroenteropancreatic neuroendocrine tumor patients. J Nucl Med. 2024;65:1584. https:\/\/doi.org\/10.2967\/jnumed.124.267964.","journal-title":"J Nucl Med"},{"key":"1937_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11604-024-01529-z","volume":"42","author":"Y Ueki","year":"2024","unstructured":"Ueki Y, Otsuka H, Tamaki O, Kasai R, Otomi Y, Ikemitsu D, et al. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors. Jpn J Radiol. 2024;42:519\u201335. https:\/\/doi.org\/10.1007\/s11604-024-01529-z.","journal-title":"Jpn J Radiol"},{"key":"1937_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13550-025-01250-6","volume":"15","author":"I Megherbi","year":"2025","unstructured":"Megherbi I, Hoog C, Perrier M, Brixi H, Cadiot G, Hoeffel-Fornes C, et al. Quantitative 177Lu-DOTATATE SPECT\/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study. EJNMMI Res. 2025;15:53. https:\/\/doi.org\/10.1186\/s13550-025-01250-6.","journal-title":"EJNMMI Res"},{"key":"1937_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-022-05977-5","volume":"50","author":"GJC Zwezerijnen","year":"2023","unstructured":"Zwezerijnen GJC, Eertink JJ, Ferr\u00e1ndez MC, Wiegers SE, Burggraaff CN, Lugtenburg PJ, et al. Reproducibility of [18F]FDG PET\/CT liver SUV as reference or normalisation factor. Eur J Nucl Med Mol Imaging. 2023;50:486\u201393. https:\/\/doi.org\/10.1007\/s00259-022-05977-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1937_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40658-021-00397-0","volume":"8","author":"J Tran-Gia","year":"2021","unstructured":"Tran-Gia J, et al. A multicentre and multi-national evaluation of the accuracy of quantitative 177Lu SPECT\/CT imaging performed within the MRT Dosimetry project. EJNMMI Phys. 2021;8:55.","journal-title":"EJNMMI Phys"},{"issue":"Suppl 1","key":"1937_CR15","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","volume":"50","author":"R Boellaard","year":"2009","unstructured":"Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):11S-20S. https:\/\/doi.org\/10.2967\/jnumed.108.057182.","journal-title":"J Nucl Med"},{"issue":"4","key":"1937_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00259-019-04439-9","volume":"47","author":"J Graf","year":"2020","unstructured":"Graf J, Pape UF, Jann H, et al. Prognostic significance of somatostatin receptor heterogeneity in progressive neuroendocrine tumors treated with 177Lu-DOTATOC or 177Lu-DOTATATE. Eur J Nucl Med Mol Imaging. 2020;47(4):881\u2013894.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1937_CR17","first-page":"652","volume":"33","author":"EP Krenning","year":"1992","unstructured":"Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med. 1992;33:652\u20138.","journal-title":"J Nucl Med"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01937-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:47:46Z","timestamp":1777970866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01937-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01937-9","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests related to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Tokushima University (approval number 4174\u20134).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants before any study-related examinations. The study was explained using an information sheet prepared by the principal investigator, and understanding was confirmed before consent. Consent forms were signed and dated by both the participant and the investigator, and copies were provided to participants. For participants unable to sign, consent was obtained from a legally authorized representative.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}